Correlation Between Sana Biotechnology and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Sana Biotechnology and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Hepion Pharmaceuticals.
Diversification Opportunities for Sana Biotechnology and Hepion Pharmaceuticals
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sana and Hepion is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sana Biotechnology and Hepion Pharmaceuticals
Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the Hepion Pharmaceuticals. In addition to that, Sana Biotechnology is 1.69 times more volatile than Hepion Pharmaceuticals. It trades about -0.38 of its total potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about 0.04 per unit of volatility. If you would invest 66.00 in Hepion Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 1.00 from holding Hepion Pharmaceuticals or generate 1.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sana Biotechnology vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Sana Biotechnology |
| Hepion Pharmaceuticals |
Sana Biotechnology and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sana Biotechnology and Hepion Pharmaceuticals
The main advantage of trading using opposite Sana Biotechnology and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |